| 产品编号 | CFN91721 | |
| CAS编号 | 85-32-5 | |
| 分子式 = 分子量 | C10H14N5O8P = 363.22 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 鸟苷酸 | CFN91721 | 85-32-5 | 10mg | QQ客服:1457312923 |
| 鸟苷酸 | CFN91721 | 85-32-5 | 20mg | QQ客服:1457312923 |
| 鸟苷酸 | CFN91721 | 85-32-5 | 50mg | QQ客服:1457312923 |
| 鸟苷酸 | CFN91721 | 85-32-5 | 100mg | QQ客服:1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway. IC50 & Target:Human Endogenous Metabolite |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7532 mL | 13.7658 mL | 27.5315 mL | 55.063 mL | 68.8288 mL |
| 5 mM | 0.5506 mL | 2.7532 mL | 5.5063 mL | 11.0126 mL | 13.7658 mL |
| 10 mM | 0.2753 mL | 1.3766 mL | 2.7532 mL | 5.5063 mL | 6.8829 mL |
| 50 mM | 0.0551 mL | 0.2753 mL | 0.5506 mL | 1.1013 mL | 1.3766 mL |
| 100 mM | 0.0275 mL | 0.1377 mL | 0.2753 mL | 0.5506 mL | 0.6883 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 11-脱羟基-16-氧代泽泻醇A; 11-Anhydro-16-oxoalisol A | CFN89426 | 156338-93-1 | C30H46O5 = 486.68 | 10mg | QQ客服:3257982914 |
| 3,4-O-异亚丙基莽草酸; 3,4-O-Isopropylidene shikimic acid | CFN99852 | 183075-03-8 | C10H14O5 = 214.2 | 5mg | QQ客服:215959384 |
| 3,4,5-三咖啡酰奎宁酸; 3,4,5-Tricaffeoylquinic acid | CFN90238 | 86632-03-3 | C34H30O15 = 678.59 | 5mg | QQ客服:2056216494 |
| 棘囊酸-28-O-beta-D-葡萄糖苷; Echinocystic acid 28-O-beta-D-glucoside | CFN91759 | 99633-30-4 | C36H58O9 = 634.84 | 5mg | QQ客服:2056216494 |